ZA918117B - Medicaments - Google Patents
MedicamentsInfo
- Publication number
- ZA918117B ZA918117B ZA918117A ZA918117A ZA918117B ZA 918117 B ZA918117 B ZA 918117B ZA 918117 A ZA918117 A ZA 918117A ZA 918117 A ZA918117 A ZA 918117A ZA 918117 B ZA918117 B ZA 918117B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- date apr
- sec
- pub
- headache
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909022250A GB9022250D0 (en) | 1990-10-12 | 1990-10-12 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA918117B true ZA918117B (en) | 1992-08-26 |
Family
ID=10683660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA918117A ZA918117B (en) | 1990-10-12 | 1991-10-11 | Medicaments |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5376672A (de) |
| EP (1) | EP0552205B1 (de) |
| JP (1) | JP3159263B2 (de) |
| KR (1) | KR0178762B1 (de) |
| AT (1) | ATE168006T1 (de) |
| AU (1) | AU660153B2 (de) |
| CA (1) | CA2093527A1 (de) |
| DE (1) | DE69129750T2 (de) |
| DK (1) | DK0552205T3 (de) |
| ES (1) | ES2118090T3 (de) |
| GB (1) | GB9022250D0 (de) |
| IE (1) | IE913580A1 (de) |
| IL (1) | IL99715A (de) |
| TW (1) | TW212756B (de) |
| WO (1) | WO1992006688A1 (de) |
| ZA (1) | ZA918117B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1147776B1 (de) * | 1993-12-28 | 2010-12-15 | Allergan, Inc. | Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Behandlung von Muskelkrämpfen |
| EP1609477B1 (de) * | 1994-12-12 | 2011-11-09 | Omeros Corporation | Bespüllungslösung und deren Verwendung zur perioperativen Hemmung von Schmerzen, Entzündungen und/oder Spasmen an einer Gefässstruktur |
| US20040068000A1 (en) * | 2002-10-02 | 2004-04-08 | Mintong Guo | Compression coated tablets |
| US20080213363A1 (en) * | 2003-01-23 | 2008-09-04 | Singh Nikhilesh N | Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa |
| WO2005123043A2 (en) * | 2004-06-10 | 2005-12-29 | Duramed Pharmaceuticals, Inc. | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| SI2124556T1 (sl) | 2006-10-09 | 2015-01-30 | Charleston Laboratories, Inc. | Farmacevtske sestave |
| US8124126B2 (en) | 2008-01-09 | 2012-02-28 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
| US8304179B2 (en) * | 2009-05-11 | 2012-11-06 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method for manufacturing a semiconductor device using a modified photosensitive layer |
| US20100287502A1 (en) * | 2009-05-11 | 2010-11-11 | Olympus Imaging Corp. | Image search device and image search method |
| EP2451274B1 (de) | 2009-07-08 | 2017-10-04 | Charleston Laboratories, Inc. | Pharmazeutische zusammensetzungen |
| JP2019507181A (ja) | 2016-03-04 | 2019-03-14 | チャールストン ラボラトリーズ，インコーポレイテッド | 医薬組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW19381A1 (en) * | 1980-08-12 | 1983-03-09 | Glaxo Group Ltd | Heterocyclic compounds |
| GR79215B (de) * | 1982-06-07 | 1984-10-22 | Glaxo Group Ltd | |
| GB8332437D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
| GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
| GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
-
1990
- 1990-10-12 GB GB909022250A patent/GB9022250D0/en active Pending
-
1991
- 1991-10-11 WO PCT/GB1991/001768 patent/WO1992006688A1/en active IP Right Grant
- 1991-10-11 DE DE69129750T patent/DE69129750T2/de not_active Expired - Fee Related
- 1991-10-11 KR KR1019930701093A patent/KR0178762B1/ko not_active IP Right Cessation
- 1991-10-11 DK DK91917473T patent/DK0552205T3/da active
- 1991-10-11 EP EP91917473A patent/EP0552205B1/de not_active Expired - Lifetime
- 1991-10-11 ZA ZA918117A patent/ZA918117B/xx unknown
- 1991-10-11 ES ES91917473T patent/ES2118090T3/es not_active Expired - Lifetime
- 1991-10-11 IL IL9971591A patent/IL99715A/en not_active IP Right Cessation
- 1991-10-11 JP JP51611991A patent/JP3159263B2/ja not_active Expired - Fee Related
- 1991-10-11 AT AT91917473T patent/ATE168006T1/de not_active IP Right Cessation
- 1991-10-11 AU AU86422/91A patent/AU660153B2/en not_active Ceased
- 1991-10-11 CA CA002093527A patent/CA2093527A1/en not_active Abandoned
- 1991-10-11 US US08/030,387 patent/US5376672A/en not_active Expired - Lifetime
- 1991-10-16 IE IE358091A patent/IE913580A1/en not_active Application Discontinuation
- 1991-11-22 TW TW080109170A patent/TW212756B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2093527A1 (en) | 1992-04-13 |
| IL99715A (en) | 1996-01-19 |
| KR0178762B1 (ko) | 1999-03-20 |
| WO1992006688A1 (en) | 1992-04-30 |
| IE913580A1 (en) | 1992-04-22 |
| JP3159263B2 (ja) | 2001-04-23 |
| AU8642291A (en) | 1992-05-20 |
| JPH06501935A (ja) | 1994-03-03 |
| EP0552205B1 (de) | 1998-07-08 |
| ATE168006T1 (de) | 1998-07-15 |
| IL99715A0 (en) | 1992-08-18 |
| ES2118090T3 (es) | 1998-09-16 |
| AU660153B2 (en) | 1995-06-15 |
| GB9022250D0 (en) | 1990-11-28 |
| DE69129750D1 (de) | 1998-08-13 |
| EP0552205A1 (de) | 1993-07-28 |
| US5376672A (en) | 1994-12-27 |
| TW212756B (de) | 1993-09-11 |
| DK0552205T3 (da) | 1999-04-19 |
| DE69129750T2 (de) | 1998-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY112915A (en) | Multiple unit tableted dosage form 1 | |
| EG22373A (en) | New pharmaceutical formulation | |
| PH30438A (en) | Heterocyclic amines useful in the therapy of asthma and inflammation of the respiratory tract | |
| CO4340681A1 (es) | Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero | |
| NO952229D0 (no) | Anvendelse av karbamazepin og okskarbazepin ved behandling av neurologiske lesjoner relatert til traumatiske skader | |
| IT1274879B (it) | Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo. | |
| DE69326776D1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
| TR199902253T2 (xx) | �n g�z odac���nda farmas�tik maddelerin kontroll� sal�n�m�. | |
| GB9022250D0 (en) | Medicaments | |
| HU9502065D0 (en) | Application of carbamazepine and oxcarbazepine in the treatment of parkinson's disease and parkinsonian syndromes | |
| PL312219A1 (en) | Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids | |
| AU3078892A (en) | Human interleukin-8 analogs | |
| IL131084A0 (en) | The use of levobupivacaine in facial surgery | |
| DK0561846T3 (da) | 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning | |
| TW261532B (de) | ||
| AU5818394A (en) | Use of prodelphinidines for treating arthrosis | |
| SE9101840D0 (sv) | New medicinal use | |
| GR3019866T3 (en) | Medicament for treating hyperlipidaemia and/or atherosclerosis | |
| BG106534A (en) | Oral solution containing galanthamine and a sweetening agent | |
| HU9500375D0 (en) | Use of 4'-iodo-4'-deoxy-doxorubicin for the treatment of amyloidosis | |
| ZA923962B (en) | Nucleoside derivative | |
| HUT77175A (hu) | Szelegilin alkalmazása epilepsziás betegségek kezelésére használható gyógyszerkészítmények előállítására és szelegilint tartalmazó epilepsziaellenes gyógyszerkészítmények | |
| HK1005651A1 (en) | Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction | |
| ZA983211B (en) | Use of mizolastine for preparing medication for the treatment of inflammation | |
| GR3036205T3 (en) | Use of phosphorus derivatives of alkaloids for treating endocrinopathies |